本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ionis Pharmaceuticals, Inc

77.63
-0.7400-0.94%
成交量:99.91万
成交额:7,821.28万
市值:125.74亿
市盈率:-48.12
高:79.49
开:78.75
低:77.45
收:78.37
52周最高:83.61
52周最低:23.95
股本:1.62亿
流通股本:1.61亿
量比:0.51
换手率:0.62%
股息:- -
股息率:- -
每股收益(TTM):-1.6132
每股收益(LYR):-3.0358
净资产收益率:-40.04%
总资产收益率:-5.68%
市净率:20.35
市盈率(LYR):-25.57

数据加载中...

2021/03/23

重要事件披露

8-K - Current report
2021/02/24

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/24

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/05

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/14

SEC问询函

CORRESP [Cover] - Correspondence
2020/12/31

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/12/18

重要事件披露

8-K - Current report
2020/12/09

重要事件披露

8-K - Current report
2020/11/04

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/04

重要事件披露

8-K - Current report
2020/10/13

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/10/13

重要事件披露

8-K - Current report
2020/10/02

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/09/24

SEC问询函

CORRESP [Cover] - Correspondence
2020/08/31

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership